SCHEMBL1107143

SCHEMBL1107143

CCOC(=O)Cc1cccc(C)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.56
CTBP2 P56545 1/20 0.53
POLB P06746 1/20 0.51
L3MBTL1 Q9Y468 5/20 0.48
ALDH1A1 P00352 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
HPGD P15428 1/20 0.48
MEN1 O00255 1/20 0.48
NPC1 O15118 2/20 0.47
PKM P14618 1/20 0.47
NFKB1 P19838 1/20 0.47
RAB9A P51151 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
IDO1 P14902 2/20 0.46
MAPK1 P28482 1/20 0.46
MAOB P27338 1/20 0.45
TP53 P04637 1/20 0.45
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL7237803 0.94 KMT2A (0.51) KMT2ACTBP2POLBL3MBTL1ALDH1A1
SCHEMBL68412 0.91 L3MBTL1 (0.50) KMT2AL3MBTL1ALDH1A1SMN1; SMN2MEN1
SCHEMBL10791322 0.88 CTBP2 (0.49) KMT2ACTBP2POLBL3MBTL1ALDH1A1
SCHEMBL6484929 0.87 KMT2A (0.51) KMT2ACTBP2POLBL3MBTL1ALDH1A1
SCHEMBL1515865 0.86 L3MBTL1 (0.49) KMT2AL3MBTL1ALDH1A1SMN1; SMN2MEN1
SCHEMBL13948677 0.85 KMT2A (0.48) KMT2ACTBP2POLBL3MBTL1ALDH1A1
SCHEMBL11553441 0.85 CTBP2 (0.56) KMT2ACTBP2POLBL3MBTL1ALDH1A1
SCHEMBL21012091 0.85 ALDH1A1 (0.69) KMT2ACTBP2POLBL3MBTL1ALDH1A1
SCHEMBL905142 0.84 CTBP2 (0.49) CTBP2L3MBTL1ALDH1A1SMN1; SMN2NPC1
SCHEMBL3620906 0.84 PAM (0.51) KMT2AL3MBTL1ALDH1A1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250287942-A1 FORMULATIONS FOR REPELLING BEES AND OTHER INSECTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-09-18 US claimed
EP-4510829-A2 FORMULATIONS FOR REPELLING BEES AND OTHER INSECTS The Regents of University of California (US) 2025-02-26 EP claimed
WO-2023205458-A2 FORMULATIONS FOR REPELLING BEES AND OTHER INSECTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-26 WO claimed
US-20260034123-A1 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS INC (US) 2026-02-05 US disclosed
US-20250287942-A1 FORMULATIONS FOR REPELLING BEES AND OTHER INSECTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-09-18 US disclosed
EP-4562016-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME Cedilla Therapeutics, Inc. (US) 2025-06-04 EP disclosed
EP-4510829-A2 FORMULATIONS FOR REPELLING BEES AND OTHER INSECTS The Regents of University of California (US) 2025-02-26 EP disclosed
US-12186317-B2 Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase TES PHARMA S.R.L. (IT) 2025-01-07 US disclosed
WO-2024240882-A1 HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR USE IN TREATING ACUTE INFLAMMATION TES PHARMA S.R.L. (IT) 2024-11-28 WO disclosed
US-20240390371-A1 HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR TREATING ACUTE INFLAMMATION TES PHARMA S.R.L. (IT) 2024-11-28 US disclosed
CN-118496217-A Inhibitors of alpha-amino-beta-carboxyhexadienoic acid semialdehyde decarboxylase TES制药有限责任公司 2024-08-16 CN disclosed
EP-0910573-A1 NEW AMINO ACID DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS Astra Aktiebolag (SE) 1999-04-28 EP disclosed
WO-1999005123-A1 NOVEL PYRIMIDIN DERIVATIVES ASTRAZENECA UK LIMITED (GB) 1999-02-04 WO disclosed
WO-1998024780-A2 SUBSTITUTED PYRIMIDINONE AND PYRIDINONE COMPOUNDS AND THEIR USE AMGEN INC. (US) 1998-06-11 WO disclosed
WO-1997046577-A1 NEW AMINO ACID DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS ASTRA AKTIEBOLAG (SE) 1997-12-11 WO disclosed
US-4720556-A 3-oxabicyclo-(3,1,0)-hexan-2-ones ROUSSEL UCLAF (FR) 1988-01-19 US disclosed
US-4642370-A Process for the production of carboxylic acid esters THE BRITISH PETROLEUM COMPANY P.L.C. (GB) 1987-02-10 US disclosed
WO-1985000596-A1 PROCESS FOR THE PRODUCTION OF CARBOXYLIC ACID ESTERS THE BRITISH PETROLEUM COMPANY P.L.C. (GB) 1985-02-14 WO disclosed
EP-0132144-A1 Process for the production of carboxylic acid esters The British Petroleum Company p.l.c. (GB) 1985-01-23 EP disclosed
US-3940486-A Imidazole derivatives in the treatment of pain CIBA-GEIGY CORPORATION (US) 1976-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260034123-A1 CDK2 INHIBITORS AND METHODS OF USING THE SAME CDK2, CDK1, CDK20 KMT2A 607/4885CTBP2 2305/4885POLB 143/4885
US-20250287942-A1 FORMULATIONS FOR REPELLING BEES AND OTHER INSECTS ACHE, BCHE, DDT KMT2A 2629/4885CTBP2 152/4885POLB 4588/4885
US-12186317-B2 Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase ACMSD, GLS, ALDH7A1 KMT2A 1353/4885CTBP2 3909/4885POLB 2002/4885
US-20240390371-A1 HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR TREATING ACUTE INFLAMMATION NFKBIA, MPO, LITAF KMT2A 3554/4885CTBP2 2273/4885POLB 3556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.